BMC Gastroenterology (Mar 2011)

Prevalence and severity of antipsychotic related constipation in patients with schizophrenia: a retrospective descriptive study

  • Tack Jan,
  • Leucht Stefan,
  • Sweers Kim,
  • Peuskens Bie,
  • Bernagie Chiara,
  • Dockx Liesbeth,
  • De Hert Marc,
  • Van de Straete Stefan,
  • Wampers Martien,
  • Peuskens Joseph

DOI
https://doi.org/10.1186/1471-230X-11-17
Journal volume & issue
Vol. 11, no. 1
p. 17

Abstract

Read online

Abstract Background Antipsychotic are the cornerstone in the treatment of schizophrenia. They also have a number of side-effects. Constipation is thought to be common, and a potential serious side-effect, which has received little attention in recent literature. Method We performed a retrospective study in consecutively admitted patients, between 2007 and 2009 and treated with antipsychotic medication, linking different electronic patient data to evaluate the prevalence and severity of constipation in patients with schizophrenia under routine treatment conditions. Results Over a period of 22 months 36.3% of patients (99) received at least once a pharmacological treatment for constipation. On average medication for constipation was prescribed for 273 days. Severe cases (N = 50), non-responsive to initial treatment, got a plain x-ray of the abdomen. In 68.4% fecal impaction was found. Conclusion A high prevalence of constipation, often severe and needing medical interventions, was confirmed during the study period. Early detection, monitoring over treatment and early intervention of constipation could prevent serious consequences such as ileus.